R. Jork

1.0k total citations
34 papers, 872 citations indexed

About

R. Jork is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, R. Jork has authored 34 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in R. Jork's work include Neuroscience and Neuropharmacology Research (17 papers), Glycosylation and Glycoproteins Research (10 papers) and Memory and Neural Mechanisms (4 papers). R. Jork is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Glycosylation and Glycoproteins Research (10 papers) and Memory and Neural Mechanisms (4 papers). R. Jork collaborates with scholars based in Germany, Czechia and Bulgaria. R. Jork's co-authors include Klaus G. Reymann, Uwe Frey, Hansjürgen Matthies, H Matthies, Steven P. R. Rose, Irene Gerlach, B Lössner, Manfred Krug, Thomas Fahrig and Ervin Horváth and has published in prestigious journals such as Brain Research, Neuroscience and Psychopharmacology.

In The Last Decade

R. Jork

34 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Jork Germany 14 618 398 265 132 121 34 872
B Tabakoff United States 13 825 1.3× 532 1.3× 162 0.6× 136 1.0× 107 0.9× 19 1.1k
P E Simson United States 12 639 1.0× 295 0.7× 186 0.7× 122 0.9× 98 0.8× 12 821
Philippe Kachidian France 18 580 0.9× 243 0.6× 161 0.6× 58 0.4× 255 2.1× 27 873
A. M. Janson Sweden 18 506 0.8× 383 1.0× 128 0.5× 53 0.4× 198 1.6× 26 901
Evelyn Dean United States 8 780 1.3× 338 0.8× 187 0.7× 150 1.1× 62 0.5× 12 1.2k
A. Consolazione Italy 13 533 0.9× 288 0.7× 191 0.7× 36 0.3× 113 0.9× 20 749
Deirdre M. O’Leary Ireland 11 528 0.9× 330 0.8× 122 0.5× 135 1.0× 55 0.5× 15 700
Melissa D. Shumate United States 10 1.2k 1.9× 638 1.6× 240 0.9× 100 0.8× 69 0.6× 10 1.3k
Dennis Dahl United States 15 575 0.9× 318 0.8× 387 1.5× 79 0.6× 27 0.2× 25 837
Alejandra M. Pacchioni United States 15 691 1.1× 365 0.9× 179 0.7× 81 0.6× 41 0.3× 26 945

Countries citing papers authored by R. Jork

Since Specialization
Citations

This map shows the geographic impact of R. Jork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Jork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Jork more than expected).

Fields of papers citing papers by R. Jork

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Jork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Jork. The network helps show where R. Jork may publish in the future.

Co-authorship network of co-authors of R. Jork

This figure shows the co-authorship network connecting the top 25 collaborators of R. Jork. A scholar is included among the top collaborators of R. Jork based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Jork. R. Jork is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bézard, Erwan, Irene Gerlach, Rosario Moratalla, Christian E. Gross, & R. Jork. (2006). 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiology of Disease. 23(1). 77–86. 57 indexed citations
2.
Mauler, Frank, Thomas Fahrig, Ervin Horváth, & R. Jork. (2001). Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo. Brain Research. 888(1). 150–157. 72 indexed citations
3.
Rancan, Mario, Vivianne I. Otto, Volkmar Hans, et al.. (2001). Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. Journal of Neuroscience Research. 63(5). 438–446. 71 indexed citations
4.
Rancan, Mario, Vivianne I. Otto, Volkmar Hans, et al.. (2001). Upregulation of ICAM‐1 and MCP‐1 but not of MIP‐2 and sensorimotor deficit in response to traumatic axonal injury in rats. Journal of Neuroscience Research. 63(5). 438–446. 14 indexed citations
5.
Gerlach, Irene, et al.. (2000). Effects of subdural haematoma on sensorimotor functioning and spatial learning in rats. Neuropharmacology. 39(5). 817–834. 9 indexed citations
6.
Angenstein, Frank, Sabine Staak, & R. Jork. (1992). Phorbol ester-induced changes in rat hippocampal glycoprotein fucosylation. Neuroscience Letters. 135(2). 269–272. 2 indexed citations
7.
Zuschratter, Werner, et al.. (1991). Distribution of (fucogalactosyl-)epitppe expressing glycoconjugates in rat brain. Neuroreport. 2(8). 445–448. 1 indexed citations
8.
Richter, P, W. D. Pohle, G. Grecksch, et al.. (1991). Enhanced development of morphine tolerance in rats treated with 2-deoxy-d-galactose. Psychopharmacology. 104(2). 279–283. 2 indexed citations
9.
Matthies, Hansjuergen, Uwe Frey, Klaus G. Reymann, et al.. (1990). Different Mechanisms and Multiple Stages of LTP. Advances in experimental medicine and biology. 268. 359–368. 81 indexed citations
10.
Tischmeyer, Wolfgang, et al.. (1990). Accumulation of c-fos mRNA in rat hippocampus during acquisition of a brightness discrimination. Behavioral and Neural Biology. 54(2). 165–171. 72 indexed citations
11.
Reymann, Klaus G., Uwe Frey, R. Jork, & Hansjürgen Matthies. (1988). Polymyxin B, an inhibitor of protein kinase C, prevents the maintenance of synaptic long-term potentiation in hippocampal CA1 neurons. Brain Research. 440(2). 305–314. 160 indexed citations
12.
Rose, Steven P. R. & R. Jork. (1987). Long-term memory formation in chicks is blocked by 2-deoxygalactose, a fucose analog. Behavioral and Neural Biology. 48(2). 246–258. 61 indexed citations
13.
Lössner, B, et al.. (1985). Dopamine-stimulated fucosylation of brain proteins in vitro is not inhibited by puromycin.. PubMed. 44(3). 465–73. 1 indexed citations
14.
Jork, R., et al.. (1984). Dopamine stimulated L-fucose incorporation into brain proteins is related to an increase in fucokinase activity.. PubMed. 43(3). 261–70. 9 indexed citations
15.
Jork, R., et al.. (1983). The effect of dopamine on L-fucose incorporation into hippocampal and striatal slices of dopamine-supersensitive rats.. PubMed. 42(4). 419–22. 4 indexed citations
16.
Jork, R., Gisela Grecksch, & H Matthies. (1982). Apomorphine and glycoprotein synthesis during consolidation. Pharmacology Biochemistry and Behavior. 17(1). 11–13. 8 indexed citations
17.
Wetzel, Wolfram, et al.. (1980). Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats. Pharmacology Biochemistry and Behavior. 12(2). 319–322. 51 indexed citations
18.
Jork, R., et al.. (1980). Apomorphine and glycoprotein synthesis in rat hippocampus. Pharmacology Biochemistry and Behavior. 12(2). 317–318. 13 indexed citations
19.
Jork, R., B Lössner, & H Matthies. (1979). Dopamine and macromolecule synthesis in rat hippocampus. Pharmacology Biochemistry and Behavior. 11(2). 247–249. 13 indexed citations
20.
Lössner, B, et al.. (1977). [Uptake of (3H)-leucine into the total proteins of various Sommer's sectors of the rat hippocampus in vivo and in vitro].. PubMed. 36(9). 1221–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026